SUBSTITUTED BENZYLSPIROINDOLIN-2-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1
申请人:VANDERBILT UNIVERSITY
公开号:US20130123236A1
公开(公告)日:2013-05-16
In one aspect, the invention relates to substituted benzylspiroindolin-2-one analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M
1
(mAChR M
1
); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
在一个方面,该发明涉及替代苯基螺合吲哚啉-2-酮类似物化合物,其衍生物和相关化合物,这些化合物可用作肌胆碱受体M1(mAChR M1)的正向变构调节剂;制备这些化合物的合成方法;包含这些化合物的药物组合物;以及使用这些化合物和组合物治疗与肌胆碱受体功能障碍相关的神经系统和精神疾病的方法。本摘要旨在作为特定领域搜索的扫描工具,并不意在限制本发明。